Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28357
Title: Variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy.
Austin Authors: Bott, Laura C;Forouhan, Mitra;Lieto, Maria;Sala, Ambre J;Ellerington, Ruth;Johnson, Janel O;Speciale, Alfina A;Criscuolo, Chiara;Filla, Alessandro;Chitayat, David;Alkhunaizi, Ebba;Shannon, Patrick;Nemeth, Andrea H;Angelucci, Francesco;Lim, Wooi Fang;Striano, Pasquale;Zara, Federico;Helbig, Ingo;Muona, Mikko;Courage, Carolina;Lehesjoki, Anna-Elina;Berkovic, Samuel F ;Fischbeck, Kenneth H;Brancati, Francesco;Morimoto, Richard I;Wood, Matthew J A;Rinaldi, Carlo
Affiliation: Epilepsy Research Centre
Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples 80121, Italy
Institute for Research, Hospitalization and Health Care (IRCCS) "G. Gaslini" Institute, Genova 16147, Italy
Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA 19104, USA
Oxford Harrington Rare Disease Centre, University of Oxford, Oxford OX1 3QX, UK
Department of Physiology, Anatomy and Genetics, Oxford OX1 3QX, UK
Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada
The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA
The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA
Department of Biomedical and Health Informatics (DBHi), Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA
Blueprint Genetics, 02150 Espoo, Finland
Folkhälsan Research Center, Helsinki, Finland
Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki, 00290, Finland
Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 Coppito, L'Aquila, Italy
Department of Paediatrics, University of Oxford, Oxford OX1 3QX, UK
Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, MD 20892, USA
Department of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, IL 60208, USA
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
IRCCS San Raffaele Pisana, 00163 Roma, Italy
Issue Date: 2021
Date: 2021
Publication information: Brain Communications 2021; 3(4): fcab245
Abstract: The vacuolar H+-ATPase is a large multi-subunit proton pump, composed of an integral membrane V0 domain, involved in proton translocation, and a peripheral V1 domain, catalysing ATP hydrolysis. This complex is widely distributed on the membrane of various subcellular organelles, such as endosomes and lysosomes, and plays a critical role in cellular processes ranging from autophagy to protein trafficking and endocytosis. Variants in ATP6V0A1, the brain-enriched isoform in the V0 domain, have been recently associated with developmental delay and epilepsy in four individuals. Here, we identified 17 individuals from 14 unrelated families with both with new and previously characterized variants in this gene, representing the largest cohort to date. Five affected subjects with biallelic variants in this gene presented with a phenotype of early-onset progressive myoclonus epilepsy with ataxia, while 12 individuals carried de novo missense variants and showed severe developmental and epileptic encephalopathy. The R740Q mutation, which alone accounts for almost 50% of the mutations identified among our cases, leads to failure of lysosomal hydrolysis by directly impairing acidification of the endolysosomal compartment, causing autophagic dysfunction and severe developmental defect in Caenorhabditis elegans. Altogether, our findings further expand the neurological phenotype associated with variants in this gene and provide a direct link with endolysosomal acidification in the pathophysiology of ATP6V0A1-related conditions.
URI: https://ahro.austin.org.au/austinjspui/handle/1/28357
DOI: 10.1093/braincomms/fcab245
ORCID: https://orcid.org/0000-0003-4014-3113
https://orcid.org/0000-0003-4580-841X
https://orcid.org/0000-0002-6065-1476
Journal: Brain Communications
PubMed URL: 34909687
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/34909687/
Type: Journal Article
Subjects: Caenorhabditis elegans disease modelling
V-ATPase
epileptic encephalopathy
lysosomal disease
organelle acidification
Appears in Collections:Journal articles

Show full item record

Page view(s)

52
checked on Feb 11, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.